business insider retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and Drug Retatrutide Phase 3: 60% Achieved

Their use also skyrocketed among women aged 18 to 25 by 659 percent

These include: Nausea (affecting 20-40% of patients initially) Vomiting Diarrhoea Constipation Abdominal discomfort These effects typically arise from delayed gastric emptying and direct effects on the gastrointestinal tract

It is currently under clinical investigation and has not yet received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)

Calcium is another essential mineral that supports bone health, but you probably already knew that

Saudi J Gastroenterol 23(2):117122 Thakur U et al (2021) Liraglutide augments weight loss after laparoscopic sleeve gastrectomy: a randomised, double-blind, placebo-control study

Frequently Asked Questions About GLP-1 & Diet What is the best diet on a GLP-1